Credit Suisse’s GoodRx Holdings GDRX Stock Holding History

Credit Suisse’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$600K	Sell	84,485 -11,048	-12%	-$73.1K	﹤0.01%	2553
2023 Q4	$640K	Buy	95,533 +286	+0.3%	+$1.61K	﹤0.01%	2607
2023 Q3	$536K	Buy	95,247 +4,279	+5%	+$28.5K	﹤0.01%	2653
2023 Q2	$502K	Buy	90,968 +624	+0.7%	+$3.36K	﹤0.01%	2773
2023 Q1	$565K	Buy	90,344 +9,252	+11%	+$51.6K	﹤0.01%	2685
2022 Q4	$378K	Sell	81,092 -3,258	-4%	-$16.1K	﹤0.01%	2931
2022 Q3	$394K	Sell	84,350 -167,132	-66%	-$1.05M	﹤0.01%	2934
2022 Q2	$1.49M	Buy	251,482 +40,622	+19%	+$452K	﹤0.01%	2109
2022 Q1	$4.08M	Sell	210,860 -12,269	-5%	-$281K	﹤0.01%	1610
2021 Q4	$7.29M	Buy	223,129 +117,745	+112%	+$4.74M	﹤0.01%	1734
2021 Q3	$4.32M	Sell	105,384 -104,614	-50%	-$3.8M	﹤0.01%	2187
2021 Q2	$7.56M	Buy	209,998 +85,834	+69%	+$3.17M	﹤0.01%	1754
2021 Q1	$4.84M	Sell	124,164 -42,678	-26%	-$1.92M	﹤0.01%	2091
2020 Q4	$6.73M	Buy	+166,842	New	+$7.67M	﹤0.01%	1862

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Credit Suisse's GDRX Position: Q1 2024 in Review

Credit Suisse reduced its GoodRx Holdings (GDRX) stake by 12% in Q1 2024, selling an estimated $73.1K and leaving 84,485 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #2553.

Credit Suisse first reported a position in GDRX in Q4 2020 and has held it in 14 quarters since. The position peaked at $7.56M in Q2 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

Credit Suisse held 84,485 shares of GoodRx Holdings worth $600K as of Q1 2024.
Credit Suisse sold 11,048 GoodRx Holdings shares in Q1 2024, an estimated $73.1K.
GoodRx Holdings made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2553 holding.
Credit Suisse first reported a position in GoodRx Holdings in Q4 2020 and has held it in 14 quarters since.
Credit Suisse's GoodRx Holdings position peaked at $7.56M in Q2 2021.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.